COL18A1 and familial pancreatic carcinoma: We also assayed whether varying concentrations of pancreatic cancer extract could inhibit the degradation of endostatin by normal pancreatic tissue but found no inhibition (data not shown) indicating that the effects of pancreatic cancer tissue were not due to the synthesis of a protease inhibitor.